(NASDAQ: ITRI), which is innovating new ways for utilities and cities to manage energy and water, announced the integration of Itron’s Intelligent Connectivity suite with FirstNet ®, Built with AT&T, ...
(MENAFN- GlobeNewsWire - Nasdaq) For the 10th year ... Please visit to make a $17 sponsorship that supports the year-round mission and places a veteran's wreath for an American hero this year or to ...
Lete-cel is being investigated for the treatment of synovial sarcoma and myxoid/round cell liposarcoma (MRCLS) in the pivotal IGNYTE-ESO (NCT03967223) trial in patients who received prior ...
The live audio webcast will be available to all interested parties through a live audio webcast accessible on the Company's Investor Relations website at https://investors.missionproduce.com/.
His comments come a day after the stock market soared to record highs following Donald Trump's election win, with the Dow ...
After moving sharply higher over the two previous sessions, stocks showed another strong move to the upside during trading on ...
2-Year U.S. Treasury Note Continuous Contract $102.613-0.055-0.05% 5-Year U.S. Treasury Note Continuous Contract $106.609-0.133-0.12% 10-Year U.S. Treasury Note Continuous Contract $109.656-0.250 ...
Haoxi Health Technology (HAO) announced that the company received a letter from the Nasdaq, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in ...
New York ,NY, Nov. 11, 2024 (GLOBE NEWSWIRE) -- WorldInvest.org Achieves Global Recognition with Nasdaq Display. WorldInvest.org, a leading online financial platform, marked a major milestone in its ...
Stock futures are near flat Wednesday night after a huge market rally following Donald Trump's decisive victory in the ...
OXNARD, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Mission Produce, Inc. (NASDAQ: AVO) (“Mission” or “the Company”) a world leader in sourcing, producing, and distributing fresh Hass avocados, today ...
Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the ...